As far as I'm aware Seroxat is the only SSRi in the UK that is currently going through the High Court with regard to it being a defective product. With the recent press reports, it would appear that it is defective. GSK lawyers can argue that it is only as defective as other SSRi's on the market - not much of an argument but one that they will no doubt use. Probably another reason why the MHRA won't intervene and say 'enough is enough.' To pull Seroxat would have a devastating effect on the outcome of any lawsuit.
from the google cache of - http://fiddaman.blogspot.co.uk/2009/08/seroxat-in-media.html